The latest financial statement is for the quarter ending 2026-03-31.
| Cash Flow | 2026-03-31 | 2025-12-31 |
|---|---|---|
| Net income | 48,900 | 177,700 |
| Net income from discontinued operations | - | 0 |
| Depreciation and amortization | 22,900 | 91,700 |
| Provision for credit losses | 10,300 | 42,400 |
| Deferred income taxes | 2,600 | -31,900 |
| Amortization of debt issuance costs | 2,400 | 8,900 |
| Stock-based compensation | 9,400 | 14,600 |
| Contingent consideration adjustment | - | 0 |
| Investment and note receivable impairment | - | 0 |
| Loss on sale of property | - | -7,000 |
| Gain on sale of business | - | 0 |
| Goodwill and other intangibles impairment | - | 0 |
| Loss on extinguishment of debt | - | 0 |
| Other non-cash, net | -400 | -400 |
| Trade receivables and other assets | 140,200 | 69,100 |
| Accounts payable and accrued expenses | 202,900 | 150,200 |
| Payments of contingent consideration in excess of acquisition-date fair value | - | 0 |
| Net cash provided by operating activities - continuing operations | - | 391,900 |
| Net cash used by operating activities - discontinued operations | - | 0 |
| Net cash provided by operating activities | 159,600 | - |
| Net increase in finance receivables held for investment | 30,500 | 135,300 |
| Acquisition of businesses (net of cash acquired) | - | 0 |
| Purchases of property, equipment and computer software | 13,100 | 55,400 |
| Investments in securities | 1,100 | 1,500 |
| Proceeds from sale of investments | - | 800 |
| Proceeds from note receivable | - | 0 |
| Proceeds from the sale of business | - | 0 |
| Proceeds from the sale of property and equipment | 0 | 42,400 |
| Net cash used by investing activities - continuing operations | - | -149,000 |
| Net cash provided by investing activities - discontinued operations | - | 0 |
| Net cash used by investing activities | -44,700 | - |
| Net increase (decrease) in book overdrafts | 3,100 | -5,900 |
| Net borrowings from lines of credit | 19,600 | -24,200 |
| Net decrease in obligations collateralized by finance receivables | -63,100 | 82,400 |
| Proceeds from long-term debt | - | 547,300 |
| Payments for debt issuance costs/amendments | 0 | 6,900 |
| Payments on long-term debt | 1,400 | 210,000 |
| Payment for early extinguishment of debt | - | 0 |
| Payments on finance leases | - | 0 |
| Payments of contingent consideration and deferred acquisition costs | - | 0 |
| Issuance of common stock under stock plans | 3,300 | 9,600 |
| Tax withholding payments for vested rsus | 9,200 | 6,700 |
| Repurchase and retirement of common stock | 25,700 | 45,600 |
| Repurchase and retirement of series a preferred stock | - | 559,300 |
| Dividends paid on series a preferred stock | 5,300 | 38,600 |
| Net cash used by financing activities - continuing operations | - | -257,900 |
| Net cash provided by financing activities - discontinued operations | - | 0 |
| Net change in cash balances of discontinued operations | - | 0 |
| Net cash used by financing activities | -78,700 | - |
| Effect of exchange rate changes on cash | -4,700 | 16,700 |
| Net increase in cash, cash equivalents and restricted cash | 31,500 | 1,700 |
| Cash and cash equivalents at beginning of period | - | 183,700 |
| Cash, cash equivalents and restricted cash at beginning of period | 185,400 | - |
| Cash and cash equivalents at end of period | - | 185,400 |
| Cash, cash equivalents and restricted cash at end of period | 216,900 | - |
OPENLANE, Inc. (OPLN)
OPENLANE, Inc. (OPLN)